Skip to main content
Cureus logoLink to Cureus
. 2022 Dec 29;14(12):e33080. doi: 10.7759/cureus.33080

Assessment of Glycemic Control in Patients With Diabetes in Northern Sudan Using Calculated HbA1c

Omer Abdel bagi 1,, Ashraf Ewis 2
Editors: Alexander Muacevic, John R Adler
PMCID: PMC9883808  PMID: 36721598

Abstract

Background: Diabetes mellitus (DM) significantly burdens health services worldwide. As a simple and cost-effective method, the mathematical calculation of HbA1c is coming to be of value in areas with scarce resources. This study aimed to use calculated HbA1c to ascertain the prevalence of uncontrolled DM and correlate it with the risk factors for DM.

Methods: In the River Nile State of northern Sudan, a cross-sectional study was conducted in five leading cities from May to August 2021. Patients diagnosed and recorded as having type 2 or type 1 DM were included in this study. Enzymatic methods were used to assess fasting blood glucose (FBG). We used the mean of three FBG readings for three months to calculate HbA1c using the equation {HbA1c = (FBG mg/dl) x 0.03+2.6}, which was used to compute the estimated mediocre blood sugar over the course of three months.

Results: A total of 2047 diabetic patients from northern Sudan were studied for their DM control. Nearly two-thirds (65.2%) had uncontrolled DM. Of the patients studied, uncontrolled DM was significantly positively associated with older age, history of ischemic heart disease, and being a housewife. Multivariate regression analysis showed significant correlations between uncontrolled DM, an inactive lifestyle, and obesity.

Conclusion: The prevalence of uncontrolled DM among known patients with diabetic in northern Sudan is high (65.2%). The inactive lifestyles of housewives and freelance workers, having type 1 DM, and being hypertensive and obese are risk factors significantly associated with uncontrolled DM and its related complications.

Keywords: fasting blood glucose (fbg), diabetes mellitus, sudan, glycemic control, calculated hba1c

Introduction

Diabetes mellitus (DM) significantly burdens health services worldwide [1]. Around 642 million adults are expected to have diabetes in 2040 in low- and middle-income countries (LMICs) [2]. Countries moving from low to middle-income levels will show a high prevalence of diabetes due to lifestyle changes [3]. In Sudan, around 7.7% of adults are affected by diabetes, and the rate is increasing progressively [4,5]. A severe scarcity of healthcare workers exists in rural Sudan, and the problem is exacerbated by the inequitable allocation of health services [2]. Over 20 million Africans live with DM, which is alarming since the increasing prevalence of diabetes is a significant challenge to the healthcare system currently and in the future [6]. The overall prevalence of DM in north Sudan approaches 20 much higher than in 1998 (8.3%) [3]. Recent studies, in Suan showed that around 22.1% of adults were affected by DM in 2019, and the prevalence is expected to be 23.5% and 24.2% in 2030 and 2045, respectively [7-9]. Checking glycemic control in patients with diabetes is of utmost importance in assessing the prognosis and modifying the risk factors [10]. Identifying the risk factors by raising awareness and educating the patients can help prevent DM-related complications [11,12]. In Sudan, the DM complication rate is estimated to be 5.44%, especially in older patients with long-duration diabetes and concomitant comorbidities. Diabetes is one of the most critical major modifiable risk factors of macro and microvascular disease, which may end up in blindness, renal failure, acute coronary syndrome (ACS), and ischemic heart disease (IHD) [13,14].

Additionally, around 10 to 25% of patients with diabetes are likely to develop diabetic foot (DF) at some stage of their lives [15,16]. Estimating the fasting blood glucose (FBG) level and glycated hemoglobin A1c (HbA1c) is the best tool for both monitoring and diagnosis of DM [10]. HbA1c is used to assess average plasma glucose level in the previous 3-4 months (life span of RBCs). HbA1c is proven to be affected by RBC’s life span (120 days), and the assessment includes all RBCs ages from oldest to youngest. Some studies revealed that if we do continuous blood glucose monitoring, the contribution of the last thirty days will be more than 50%, while the contribution of the blood glucose levels in the early 90 days contribute by only 10%, which explains the marked variation of HbA1c with a quick variation of blood glucose [17,18]. While doing an HbA1c assessment, in case of inappropriate results correlated with clinical findings, the pathologist and technologist must search for hemoglobin variants and use the appropriate method of HbA1c assessment since some interfere with enzymatic processes. In contrast, others interfere with immunoassay [18]. Being simple and cost-effective, the mathematical calculation of HbA1c is becoming of value in areas with insufficient resources [19]. In areas with low resources, such as our setting in northern Sudan, the availability of HbA1c assessment is a big issue; hence the calculated HbA1c is a reasonable solution to assess glycemic control [19]. This study aims to use the calculated HbA1c to assess the prevalence of uncontrolled DM and correlate it with the risk factors of DM.

Materials and methods

Study area and design: In the River Nile State in northern Sudan, this cross-sectional study was conducted in the five main cities of Ad-dammar, Atbara, Shandi, Abu Hamed, and Berber from May to August 2021.

Study population: Patients diagnosed and recorded with type 2 or type 1 DM for at least a year in the five cities were included in this study. Patients aged less than 18 years, pregnant, elderly with poor mental competence, and morbidly ill patients were excluded from the study. Elsheikh Abdullah Elbadry University granted ethics approval for this study (2021/2). All procedures were carried out in line with the Helsinki Declaration. All participants provided informed consent.

Methods: Enzymatic methods were used to assess FBG using a calibrated, fully automated chemical analyzer (Biosystems analyzer A 15 Barcelona- Spain). If FBG is less than 130 mg/dl (7.2 ml mole per liter), it indicates reasonable glycemic control. But when FBG equals 130 mg/dl or more, the glycemic control is poor. The American Diabetes Association (ADA) claims that blood sugar control is defined as HbA1c less than 7% for excellent control and more than 7% for poor control [19]. The literature revealed a clear linkage between the FBG and HbA1c; we use the mean of three FBG readings for three months to calculate HbA1c using the equation {HbA1c = (FBG mg/dl) x 0.03+2.6} which is used to compute the estimated mediocre blood sugar over the course of three months. A qualified nurse measured blood pressure, and hypertension was defined as a patient who was already taking antihypertensive medication or whose blood pressure after three separate measurements was > 140/90 mmHg. Participants weighed themselves on a Seca scale while wearing no shoes. A standard height board was used to measure their heights. Body mass index (BMI) is computed by dividing weight in kilograms by height in square meters, normal (< 25/kg/m2), overweight (25-29.99 kg/m2), and obese (greater than 30 kg/m2).

Data collection: A well-prepared questionnaire was utilized to collect sociodemographic data, family history, diabetes duration, residency, and comorbidities.

Statistical analysis: Data analysis was performed using the statistical package for social sciences (SPSS) for Windows was used to analyze the data (version 25.0). The proportion of patients with controlled and uncontrolled DM was compared using the Chi-squared test. Odd’s ratio (OR) and the adjusted OR (AOR) were calculated to assess the risk factors. The independent variable was incorporated into the multivariate logistic regression analysis model. P-values of less than 0.05 were considered significant.

Results

A total of 2047 patients with diabetes from northern Sudan were studied for their DM control. Nearly two-thirds (65.2%) of the patients had uncontrolled DM. The number of females (54.1%) was slightly higher than males, with the mean age of the studied patients being 56.45 (±12.43) years. Most (70%) of the patients were of type 2 DM, with a mean disease duration of 6.76 years. Almost half of the patients with diabetes had a positive family history of DM. The dominant occupation was a housewife and the major contribution of participants was from Atbara (45%) (Table 1).

Table 1. Sociodemographic data and clinical characteristics of the studied adult diabetic patients from Sudan.

Variable Frequency Percent
Sex Female 1110 54.2%
Male 937 45.8%
Occupation Housewife 880 43.0%
Employee 581 28.4%
Student 67 3.3%
Freelancer 519 25.4%
Housewife 880 43.0%
City Barbar 464 22.7%
Abu Hamad 344 16.8%
Atbara 555 27.1%
Al Damar 375 18.3%
Shandi 309 15.1%
Diabetes type Type 1 612 29.9%
Type II 1435 70.1%
Hypertension Absent 1072 52.4%
Present 975 47.6%
Duration Less than 5 years  697 34.0%
5 years and above 1350 66.0%
Fasting blood glucose less than 130 mg/dl 713 34.8%
130 mg/dl and above 1334 65.2%
Body mass index Underweight 23 1.1%
Normal 483 23.6%
Overweight 760 37.1%
Obese 1 448 21.9%
Obese 2 333 16.3%

In the patients studied, uncontrolled DM was significantly associated with age, history of IHD, being a housewife, residency in Barbar and Atbara, obesity, having type 2 DM, incantatory uncontrolled diabetes not affected by family history or those who are less than 50 years (Table 2).

Table 2. Comparison between the controlled and uncontrolled diabetes mellitus among the studied adult diabetic patients from Sudan.

  FBG < 130 mg/dl FBG ≥ 130 mg/dl p-value
(N=713) (N=1334)
Age (y) Mean ±SD (Range) 55.7±10.1 (22-83) 56.9±13.5 (15-84) 0.038*
Age ≥30 ≥ 30 y 709 (99.4%) 1271 (95.3%) <0.001*
Age ≥40 ≥ 40 y 665 (93.3%) 1219 (91.4%) 0.133
Age ≥50 ≥ 50 y 599 (84%) 1030 (77.2%) <0.001*
Sex Female 371 (52%) 739 (55.4%) 0.146
  Male 342 (48%) 595 (44.6%)
Occupation Housewife 291 (40.8%) 589 (44.2%) <0.001*
  Employee 261 (36.6%) 320 (24%) *
  Student 4 (0.6%) 63 (4.7%) *
  Freelancer 157 (22%) 362 (27.1%) *
City Barbar 167 (23.4%) 297 (22.3%) <0.001*
  Abu Hamad 137 (19.2%) 207 (15.5%) *
  Atbara 216 (30.3%) 339 (25.4%) *
  Al Damar 130 (18.2%) 245 (18.4%)
  Shandi 63 (8.8%) 246 (18.4%) *
Diabetes type Type 1 137 (19.2%) 475 (35.6%) <0.001*
  Type II 576 (80.8%) 859 (64.4%)
Disease duration Mean±SD (Range) 7.1±5.1 (1-20) 6.5±4.4 (1-20) 0.006*
  Less than 5 years 224 (31.4%) 473 (35.5%) 0.066
5 years and above 489 (68.6%) 861 (64.5%)
Diabetic foot No 637 (89.3%) 1150 (86.2%) 0.042*
  Yes 76 (10.7%) 184 (13.8%)
Hypertension Absent 431 (60.4%) 641 (48.1%) <0.001*
  Present  282 (39.6%) 693 (51.9%)
Family history No 398 (55.8%) 704 (52.8%) 0.188
  Yes 315 (44.2%) 630 (47.2%)
Ischemic heart disease No 690 (96.8%) 1320 (99%) <0.001*
  Yes 23 (3.2%) 14 (1%)
Body mass index Mean ±SD (Range) 28.95±5.77 (15.8-45.6) 28.99±5.77 (14.4-45.2) 0.879
  Underweight 6 (0.8%) 17 (1.3%) <0.001*
Normal 158 (22.2%) 325 (24.4%)  
Overweight 309 (43.3%) 451 (33.8%) *  
Obese 1 123 (17.3%) 325 (24.4%) *  
Obese 2 117 (16.4%) 216 (16.2%)  
Obese BMI ≥ 30 240 (33.7%) 541 (40.6%) 0.002*
  BMI < 30 473 (66.3%) 793 (59.4%)

A multivariate regression analysis showed that there were significant correlations between uncontrolled DM and having an occupation as an employee (AOR = 0.46 (0.37-0.59), p <0.001), type 1 DM (AOR = 2.52 (1.98-3.2), p <0.001), hypertension (AOR 1.51 (1.24-1.84) p <0.001), and obesity (AOR 1.36 (1.11-1.67) p<0.003) (Table 3).

Table 3. Univariate and multivariate analysis of the factors associated with uncontrolled diabetes mellitus among the studied adult diabetic patients from Sudan.

  Univariate analysis Multivariate analysis
Crude OR (95% CI) p-value AOR (95% CI) p-value
Age (≥ 30 y) 0.11 (0.04-0.31) <0.001*    
Sex (male) 1.15 (0.95-1.37) 0.146    
Occupation        
Housewife 1 (reference)      
Employee 0.61 (0.49-0.75) <0.001* 0.46 (0.37-0.59) <0.001*
Student 7.78 (2.81-21.59) <0.001* 3.8 (1.33-10.83) 0.013*
Freelancer 1.14 (0.9-1.44) 0.275 1.04 (0.82-1.33) 0.741
Diabetes type (Type 1) 2.33 (1.87-2.89) <0.001* 2.52 (1.98-3.2) <0.001*
Disease duration (y) 0.97 (0.96-0.99) 0.006* 0.97 (0.95-0.99) 0.002*
Diabetic septic foot 1.34 (1.01-1.78) 0.043*    
Hypertension 1.65 (1.37-1.99) <0.001* 1.51 (1.24-1.84) <0.001*
Family history 1.13 (0.94-1.36) 0.188    
Body mass index 1 (0.99-1.02) 0.879    
Obese 1.35 (1.11-1.63) 0.002* 1.36 (1.11-1.67) 0.003*

Discussion

In this study, we used calculated HbA1c to assess glycemic control, drawing on previous valuable and reliable research. The relationship between HbA1c and FBG is evident, especially in diabetic patients [20]. Ghazanfari et al. (2010) studied the relationship between HbA1c and FBG and concluded that FBG is an accurate predictor of HbA1c. Moreover, in a comparative study using high-pressure liquid chromatography (HPLC) and cost-effective calculated HbA1c, Dayanand et al. (2012) found a significant association between HPLC measured and the mathematically calculated HbA1c [21-23]. In many sub-Saharan countries, including our study area, the explanation for poor glycemic control is mainly the cost of drugs and investigations; some good and effective medicines are doubtlessly beyond the reach of most patients, and some studies, in addition to a lack of awareness of long-term complications of DM [22]. Many conditions, whether pathological or physiological, can affect the results of HbA1c and must be considered when interpreting the results. These conditions include hemoglobinopathies, uremia, pregnancy, hemodialysis, alcohol intake, and aspirin administration [23]. There is also a problem with lifelong conditions, such as hemoglobinopathies; it is worth mentioning that sickle cell anemia prevalence in Sudan ranges from 2.5 to 30% [22]. In settings like that of our current study area and similar areas in other developing countries, besides these universal problems of HbA1c investigation, there are many local obstacles, such as the availability of machines, availability and stability of electricity, availability of good quality machines, availability of calibrating and standard reagents, and the cost and charges for the relatively expensive investigations. In this study, the prevalence of uncontrolled DM was found in 65.2% of the patients with diabetes studied. Similar findings were seen in eastern Sudan, Uganda, and Saudi Arabia, where uncontrolled DM accounted for 71.9% [24], 68% [22], and 59.3% [25], respectively, indicating that using calculated HbA1c gave almost similar results to studies done by stander procedure to assess long-term glycemic control. Studies from Sudan, Ethiopia, and western Africa revealed a very high prevalence of uncontrolled DM in patients with type 2 diabetes, with scores of 85% [26], 86%, [27], and 83.8% [28], respectively. The difference is probably due to variations in the investigation methods, the number of patients studied besides patient awareness and the lack of continuous health education. Lower scores for the prevalence of uncontrolled DM were reported in studies from Nigeria (40%) [29] and Kenya (27.1%) [30]. Our study showed a strong correlation between age, history of IHD, and type 2 diabetes; this finding agrees with [31-33]. This can be explained by the strong correlation between DM and vascular disease, especially in prolonged diseases, and because type 2 diabetes is known to be a disease of older age. Being a housewife showed a strong correlation with uncontrolled DM, which is in line with the findings of other previous studies, such as a study in Nepal [34]. This can be explained by inactive lifestyle, dietary habits, and the fact that most women in this part of Sudan prefer not to work outside their houses because of tradition. There was also a relationship between a patient’s residence in Barbar and Atbara and poor glycemic control, most probably due to the semi-sedentary life in these cities. Our study showed type 1 DM to be an independent factor for poor glycemic control; this agreed with a study from Dar Es Salaam [35]. This can be explained by the fact that type 1 mainly affects children, and it is challenging to control dietary habits and proper use and storage of insulin. The current study also showed a positive correlation between hypertension risk (OR = 1.15) and uncontrolled DM, a finding similar to the results reported in Nepal [36]. Obese patients in this study showed a high risk of developing uncontrolled DM (1.36-fold), a finding like those reported by many studies from different African countries [2,6,8,10,13]. The limitation of this study includes some issues that were not addressed, such as physical activity, lipid profile, smoking, and dietary habits.

Conclusions

The prevalence of uncontrolled DM among known diabetic patients in northern Sudan is high (65.2%). The inactive lifestyles of housewives and freelance workers, having type 1 DM, and being hypertensive and obese are risk factors significantly associated with uncontrolled DM and its related complications. We recommend that calculated HbA1c be used in areas with difficulties conducting HbA1c measurements.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study. The university of Elsheikh Abdullah Elbadry-Sudan issued approval (2021/2). We obtain ethical approval for this research from the university of Elsheikh Abdullah Elbadry (2021/2). All procedures were presented in agreement with the Declaration of Helsinki. Written knowledgeable consent was obtained from all contributors.

Animal Ethics

Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue.

References

  • 1.A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Reed J, Bain S, Kanamarlapudi V. Diabetes Metab Syndr Obes. 2021;14:3567–3602. doi: 10.2147/DMSO.S319895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Economic and social impact of diabetes mellitus in a low-income country: a case-control study in Sudan. Elrayah-Eliadarous HA, Östenson CG, Eltom M, Johansson P, Sparring V, Wahlström R. J Diabetes. 2017;9:1082–1090. doi: 10.1111/1753-0407.12540. [DOI] [PubMed] [Google Scholar]
  • 3.Metabolic control targets in Sudanese adults with type 1 diabetes: a population-based study. Almobarak AO, Noor SK, Elmadhoun WM, et al. J Family Med Prim Care. 2017;6:374–379. doi: 10.4103/jfmpc.jfmpc_359_16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: a prospective, cross-sectional study at a tertiary care teaching hospital. Acharya KG, Shah KN, Solanki ND, Rana DA. J Basic Clin Pharm. 2013;4:82–87. doi: 10.4103/0976-0105.121653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Assessment of Type 2 Diabetes management practice: A study in public hospitals outpatient clinics, Khartoum and Gezira, Sudan. Elhendi MY. http://duo.uio.no 2015;678:178. [Google Scholar]
  • 6.Prediabetes progression to diabetes among veterans. Yaturu S. J Diabetes Mellit. 2020;10:202–207. [Google Scholar]
  • 7.Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Saeedi P, Petersohn I, Salpea P, et al. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. [DOI] [PubMed] [Google Scholar]
  • 8.Prevalence and risk factors for acute coronary syndrome among Sudanese individuals with diabetes: a population-based study. Ahmed MH, Awadalla H, Elmadhoun WM, Osman M, Noor SK, Almobarak AO. Cardiol Res. 2017;8:184–189. doi: 10.14740/cr616w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Inadequate control of diabetes and metabolic indices among diabetic patients: a population based study from the Kerman Coronary Artery Disease Risk Study (KERCADRS) Yousefzadeh G, Shokoohi M, Najafipour H. Int J Health Policy Manag. 2015;4:271–277. doi: 10.15171/ijhpm.2015.06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.The calculated versus the measured glycosylated haemoglobin (HbA(1c) ) levels in patients with type 2 diabetes mellitus. Musa IR, Omar SM, Sharif ME, Ahmed AB, Adam I. J Clin Lab Anal. 2021;35:0. doi: 10.1002/jcla.23873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hemostatic state augmented with platelet indices among Sudanese diabetic septic foot. Bashir BA, Ali MS. BMC Hematol. 2018;18:11. doi: 10.1186/s12878-018-0104-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Assessment of knowledge toward complications of diabetic septic foot among diabetics patients in Saudi Arabia. Alhabshan RF, Huwaymil MSB, Alsaqabi OA, Alzaid AN, Almasoud AI. Egypt J Hosp Med. 2017;69:2557–2561. [Google Scholar]
  • 13.Prevalence and associated factors of ischemic heart disease (IHD) among patients with diabetes mellitus: a nation-wide, cross-sectional survey. Sakboonyarat B, Rangsin R. BMC Cardiovasc Disord. 2018;18:1–7. doi: 10.1186/s12872-018-0887-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Atherosclerosis surrogate marker in diabetic patients. Ratki SKR, Kharaji M, Namiranian N, et al. https://doaj.org/article/7c84bbdd3f154adcabb8e1a566f186e4 IJDO. 2016;8:91–95. [Google Scholar]
  • 15.Prevalence of diabetic foot amongst adults with diabetes mellitus in northern Sudan: a cross-sectional study. Abdelbagi OM, Musa IR, Altigani SA, Osman A, Adam I. Int J Clin Pract. 2021;75:0. doi: 10.1111/ijcp.14892. [DOI] [PubMed] [Google Scholar]
  • 16.The risk factors for diabetic foot ulceration. Merza Z, Tesfaye S. The Foot. 2003;13:125–129. [Google Scholar]
  • 17.Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Diabetes Care. 2002;25:275–278. doi: 10.2337/diacare.25.2.275. [DOI] [PubMed] [Google Scholar]
  • 18.The Response of GHb to Stepwise Plasma Glucose Change Over Time in Diabetic Patients. [ Sep; 2022 ]. 1993. http://diabetesjournals.org/care/article-pdf/16/9/1313/442061/16-9-1313.pdf. http://diabetesjournals.org/care/article-pdf/16/9/1313/442061/16-9-1313.pdf [DOI] [PubMed]
  • 19.Evaluation of the ihnterference of hemoglobin variant J-Bangkok on glycated hemoglobin (HbA1c) measurement by five different methods. Wen DM, Xu SN, Wang WJ, Zhang XM, Suo MH, Zhang DC. Exp Clin Endocrinol Diabetes. 2017;125:655–660. doi: 10.1055/s-0043-118535. [DOI] [PubMed] [Google Scholar]
  • 20.Review of hemoglobin A(1c) in the management of diabetes. Gallagher EJ, Le Roith D, Bloomgarden Z. J Diabetes. 2009;1:9–17. doi: 10.1111/j.1753-0407.2009.00009.x. [DOI] [PubMed] [Google Scholar]
  • 21.Reliability of glycosylated hemoglobin in the diagnosis of gestational diabetes mellitus. Rayis DA, Ahmed AB, Sharif ME, ElSouli A, Adam I. J Clin Lab Anal. 2020;34:0. doi: 10.1002/jcla.23435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.A comparison of HbA1c and fasting blood sugar tests in general population. Ghazanfari Z, Haghdoost AA, Alizadeh SM, Atapour J, Zolala F. http://PMC3075530. Int J Prev Med. 2010;1:187–194. [PMC free article] [PubMed] [Google Scholar]
  • 23.Comparison of calculated HbA1c with measured HbA1c by high pressure liquid chromatography method. Dayanand CD, Vegi PK, Kutty AVM. http://14.139.156.51:8080/jspui/handle/123456789/1415 Int J Sci Innov Discov. 2012;2:573–579. [Google Scholar]
  • 24.Suboptimal glycaemic and blood pressure control and screening for diabetic complications in adult ambulatory diabetic patients in Uganda: a retrospective study from a developing country. Kibirige D, Atuhe D, Sebunya R, Mwebaze R. J Diabetes Metab Disord. 2014;13:1–7. doi: 10.1186/2251-6581-13-40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Going beyond HbA1c to understand the benefits of advanced diabetes therapies. Vigersky RA. J Diabetes. 2019;11:23–31. doi: 10.1111/1753-0407.12846. [DOI] [PubMed] [Google Scholar]
  • 26.Assessment of glycemic control in type 2 diabetes in the Eastern Sudan. Omar SM, Musa IR, Osman OE, Adam I. BMC Res Notes. 2018;11:1–6. doi: 10.1186/s13104-018-3480-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia. Alsulaiman TA, Al-Ajmi HA, Al-Qahtani SM, et al. J Family Community Med. 2016;23:1–5. doi: 10.4103/2230-8229.172221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Glycaemic control in Sudanese individuals with type 2 diabetes: population based study. Noor SK, Elmadhoun WM, Bushara SO, et al. Diabetes Metab Syndr. 2017;11:0–51. doi: 10.1016/j.dsx.2016.12.024. [DOI] [PubMed] [Google Scholar]
  • 29.Blood pressure and blood glucose control and associated factors among adults with hypertension at three public hospitals in Southern Ethiopia. Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T. High Blood Press Cardiovasc Prev. 2022;29:287–304. doi: 10.1007/s40292-022-00516-7. [DOI] [PubMed] [Google Scholar]
  • 30.Diabetes complications in Sudanese individuals with type 2 diabetes: Overlooked problems in sub-Saharan Africa? Awadalla H, Noor SK, Elmadhoun WM, et al. Diabetes Metab Syndr. 2017;11:0–51. doi: 10.1016/j.dsx.2017.07.039. [DOI] [PubMed] [Google Scholar]
  • 31.Glycemic control and its association with sociodemographics, comorbid conditions, and medication adherence among patients with type 2 diabetes in southwestern Nigeria. Ibrahim AO, Agboola SM, Elegbede OT, Ismail WO, Agbesanwa TA, Omolayo TA. J Int Med Res. 2021;49 doi: 10.1177/03000605211044040. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Factors associated with glycated hemoglobin levels > 6.5% among diabetic patients attending Kenyatta National Hospital, Kenya. Muringo MC, Mutai J, Gachohi J. J Diabetes Mellit. 2021;11:10–25. [Google Scholar]
  • 33.Diabetic cardiomyopathy and ischemic heart disease: prevention and therapy by exercise and conditioning. Crisafulli A, Pagliaro P, Roberto S, et al. Int J Mol Sci. 2020;21:2896. doi: 10.3390/ijms21082896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.AGEs and chronic subclinical inflammation in diabetes: disorders of immune system. Hu H, Jiang H, Ren H, Hu X, Wang X, Han C. Diabetes Metab. 2015;31:127–137. doi: 10.1002/dmrr.2560. [DOI] [PubMed] [Google Scholar]
  • 35.MPV in uncontrolled & controlled diabetics- its role as an indicator of vascular complication. Radha RK, Selvam D. J Clin Diagn Res. 2016;10:0–6. doi: 10.7860/JCDR/2016/21499.8353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Awareness and prevalence of diabetes mellitus among housewives in Baneshwar of Nepal. Sushil K, Mandira M. https://scholar.google.com/citations?view_op=view_citation&hl=en&user=NVzjCD0AAAAJ&citation_for_view=NVzjCD0AAAAJ:LkGwnXOMwfcC Indian J Basic Appl Med Res. 2017;6:543–549. [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES